Equity Overview
Price & Market Data
Price: $11.41
Daily Change: -$0.15 / 1.31%
Range: $11.10 - $11.69
Market Cap: $611,096,384
Volume: 221,933
Performance Metrics
1 Week: 0.80%
1 Month: 32.71%
3 Months: 18.21%
6 Months: -46.26%
1 Year: -46.42%
YTD: -30.90%
Company Details
Employees: 52
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, as well as in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.